Related Experiment Video
Updated: Jul 20, 2025

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Genome-wide kinase-MAM interactome screening reveals the role of CK2A1 in MAM Ca2+ dynamics linked to DEE66
Truong Thi My Nhung1, Nguyen Phuoc Long2, Tran Diem Nghi1
1Department of Life Sciences, Pohang University of Science and Technology, Pohang 37673, Republic of Korea.
Abstract:
The endoplasmic reticulum (ER) and mitochondria form a unique subcellular compartment called mitochondria-associated ER membranes (MAMs). Disruption of MAMs impairs Ca2+ homeostasis, triggering pleiotropic effects in the neuronal system. Genome-wide kinase-MAM interactome screening identifies casein kinase 2 alpha 1 (CK2A1) as a regulator of composition and Ca2+ transport of MAMs. CK2A1-mediated phosphorylation of PACS2 at Ser207/208/213 facilitates MAM localization of the CK2A1-PACS2-PKD2 complex, regulating PKD2-dependent mitochondrial Ca2+ influx. We further reveal that mutations of PACS2 (E209K and E211K) associated with developmental and epileptic encephalopathy-66 (DEE66) impair MAM integrity through the disturbance of PACS2 phosphorylation at Ser207/208/213. This, in turn, causes the reduction of mitochondrial Ca2+ uptake and the dramatic increase of the cytosolic Ca2+ level, thereby, inducing neurotransmitter release at the axon boutons of glutamatergic neurons. In conclusion, our findings suggest a molecular mechanism that MAM alterations induced by pathological PACS2 mutations modulate Ca2+-dependent neurotransmitter release.
Insights
Mitochondria-associated ER membranes (MAMs) regulate calcium (Ca2+) homeostasis. Pathological PACS2 mutations disrupt MAMs, impairing Ca2+ uptake and increasing cytosolic Ca2+, which affects neurotransmitter release in neurons.
Area of Science:
- Cell Biology
- Neuroscience
- Molecular Biology
Background:
- Mitochondria-associated ER membranes (MAMs) are crucial for cellular calcium (Ca2+) homeostasis.
- Disruption of MAMs leads to widespread effects in the nervous system.
Purpose of the Study:
- To identify kinases regulating MAM composition and Ca2+ transport.
- To elucidate the role of casein kinase 2 alpha 1 (CK2A1) and PACS2 in MAM function and neuronal Ca2+ signaling.
Main Methods:
- Genome-wide kinase-MAM interactome screening.
- Analysis of PACS2 phosphorylation and its impact on MAM localization.
- Investigation of Ca2+ homeostasis and neurotransmitter release in response to PACS2 mutations.
Main Results:
- CK2A1 was identified as a regulator of MAMs.
- CK2A1 phosphorylates PACS2, facilitating the CK2A1-PACS2-PKD2 complex at MAMs and regulating mitochondrial Ca2+ influx.
- Mutations in PACS2 associated with developmental and epileptic encephalopathy-66 (DEE66) impair MAM integrity, reduce mitochondrial Ca2+ uptake, and increase cytosolic Ca2+ levels.
Conclusions:
- Pathological PACS2 mutations disrupt MAMs, leading to altered Ca2+ signaling.
- These MAM alterations modulate Ca2+-dependent neurotransmitter release at glutamatergic synapses.
- Findings reveal a molecular mechanism linking MAM dysfunction to neurological disorders.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Protein Kinases and Phosphatases
Positive Regulator Molecules

